CDMOs offering Formulation Development with Antibody-Drug Conjugate (ADC)
23 published
23 published CDMOs match Formulation Development and Antibody-Drug Conjugate (ADC).
Locations in this set include United States, China, Germany, United Kingdom, Italy, and France.
Capabilities that show up most often in this set: CMC Analytical Development, Process Development, ADC (Antibody-Drug Conjugate) Manufacturing, Technology Transfer, and CMC Regulatory Submission Support.
Matching companies
VeranovaGlobal CDMO specializing in development and manufacturing of complex active pharmaceutical ingredients (APIs), with expertise in solid form sciences, process development, and specialty modalities including ADCs and controlled substances.
Wheeler BioOklahoma-based CDMO specializing in antibody-based therapeutics from cell line development through cGMP manufacturing. Offers ModularCMC platform with phase-appropriate work packages and high-touch project management.
WuXi XDCWuXi XDC is a leading CRDMO offering integrated discovery, development, and cGMP manufacturing services for antibody drug conjugates (ADCs) and bioconjugates, with proximately located facilities that reduce development timelines and costs.
Markdown mirror: /explore/formulation-development/antibody-drug-conjugate.md